Literature DB >> 23392811

[Stereotactic Radiofrequency Ablation (SRFA) of intrahepatic cholangiocellular carcinomas: a minimal invasive alternative to liver resection].

Reto Bale1, Peter Schullian, Marion Haidu, Gerlig Widmann.   

Abstract

Up to now resection and liver transplantation are concerned as the only curative treatment options for intrahepatic cholangiocellular carcinomas (ICCs). For patients with inoperable ICCs systemic chemotherapy and various locoregional therapies including transarterial (chemo)embolization (TACE), selective internal radiation therapy (SIRT), radiofrequency ablation (RFA) and microwave ablation (MWA) are applied. Stereotactic RFA (SRFA) allows for precise 3D planning and positioning of multiple RF electrodes. Due to overlapping necroses tumors > 5 cm can be completely ablated in one session. 17 inoperable consecutive patients with 52 ICCs were treated with stereotactic RFA (SRFA). A median overall survival of 60 months was achieved. The two largest tumors with diameters > 10 cm were completely ablated. These SRFA data of irresectable ICCs are superior to the published data on resection. SRFA is a minimal invasive alternative treatment to resection and may be considered as the first-line local treatment of patients with ICCs in selected patients.

Entities:  

Mesh:

Year:  2013        PMID: 23392811     DOI: 10.1007/s10354-013-0182-8

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  22 in total

1.  Percutaneous stereotactic radiofrequency ablation of colorectal liver metastases.

Authors:  Reto Bale; Gerlig Widmann; Peter Schullian; Marion Haidu; Georg Pall; Alexander Klaus; Helmut Weiss; Matthias Biebl; Raimund Margreiter
Journal:  Eur Radiol       Date:  2011-11-10       Impact factor: 5.315

2.  Stereotactic radiofrequency ablation of unresectable intrahepatic cholangiocarcinomas: a retrospective study.

Authors:  Marion Haidu; Georg Dobrozemsky; Peter Schullian; Gerlig Widmann; Alexander Klaus; Helmut Weiss; Raimund Margreiter; Reto Bale
Journal:  Cardiovasc Intervent Radiol       Date:  2011-10-18       Impact factor: 2.740

Review 3.  Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors.

Authors:  Stefaan Mulier; Yicheng Ni; Jacques Jamart; Theo Ruers; Guy Marchal; Luc Michel
Journal:  Ann Surg       Date:  2005-08       Impact factor: 12.969

4.  Percutaneous ultrasound-guided radiofrequency ablation of intrahepatic cholangiocarcinoma.

Authors:  Yi-You Chiou; Jen-I Hwang; Yi-Hong Chou; Hsin-Kai Wang; Jen-Huey Chiang; Cheng-Yen Chang
Journal:  Kaohsiung J Med Sci       Date:  2005-07       Impact factor: 2.744

5.  Navigated open, laparoscopic, and percutaneous liver surgery.

Authors:  R Bale; G Widmann; W Jaschke
Journal:  Minerva Chir       Date:  2011-10       Impact factor: 1.000

6.  Chemoembolization of intrahepatic cholangiocarcinoma with cisplatinum, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol: a 2-center study.

Authors:  Matthew V Kiefer; Marissa Albert; Madeline McNally; Mary Robertson; Weijing Sun; Douglas Fraker; Kim Olthoff; Kathleen Christians; Sam Pappas; William Rilling; Michael C Soulen
Journal:  Cancer       Date:  2010-11-08       Impact factor: 6.860

7.  Radiofrequency ablation of intrahepatic cholangiocarcinoma: preliminary experience.

Authors:  Gianpaolo Carrafiello; Domenico Laganà; Elisa Cotta; Monica Mangini; Federico Fontana; Francesca Bandiera; Carlo Fugazzola
Journal:  Cardiovasc Intervent Radiol       Date:  2010-04-22       Impact factor: 2.740

8.  Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution.

Authors:  Michelle L DeOliveira; Steven C Cunningham; John L Cameron; Farin Kamangar; Jordan M Winter; Keith D Lillemoe; Michael A Choti; Charles J Yeo; Richard D Schulick
Journal:  Ann Surg       Date:  2007-05       Impact factor: 12.969

9.  Transarterial chemoembolization (TACE) for inoperable intrahepatic cholangiocarcinoma.

Authors:  S Herber; G Otto; J Schneider; N Manzl; I Kummer; S Kanzler; A Schuchmann; J Thies; C Düber; M Pitton
Journal:  Cardiovasc Intervent Radiol       Date:  2007-05-17       Impact factor: 2.740

10.  [Stereotaxy and robotics for ablation - toy or tool?].

Authors:  R Bale; G Widmann; W Jaschke
Journal:  Radiologe       Date:  2012-01       Impact factor: 0.635

View more
  1 in total

1.  Integrating interventional oncology in the treatment of liver tumors.

Authors:  D Putzer; P Schullian; E Braunwarth; M Fodor; F Primavesi; B Cardini; T Resch; R Oberhuber; M Maglione; C Margreiter; S Schneeberger; S Stättner; D Öfner-Velano; W Jaschke; R J Bale
Journal:  Eur Surg       Date:  2018-04-13       Impact factor: 0.953

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.